€3.2M INOVOLINE (FUI-24) project approved for automated in vivo testing of new anticancer drugs!

INOVOTION has been awarded an ambitious project for automating its revolutionary Drug Discovery in vivo efficacy and toxicity testing technology.  The underlying technology is already a game changer for developing new anticancer drugs: in vivo efficacy and toxicity data in 1 month, x5 affordable, x1000 sensitivity, x2 reliability, no animal testing, and it’s as predictive as other more classical models.

More information

17/11/2017


Haut de page